SM-GLP1

Description

SM-GLP1 (Sema) is a premium-quality synthetic GLP-1 receptor agonist developed exclusively for in-vitro laboratory research, analytical testing, and scientific investigation. Engineered as a long-acting GLP-1 analog, SM-GLP1 is widely studied for its receptor pharmacology, peptide stability, molecular signaling, and metabolic pathway research.

Manufactured under stringent quality standards, SM-GLP1 is supplied as a highly purified lyophilized powder with ≥95% HPLC-verified purity, ensuring exceptional consistency and analytical reliability. Every batch undergoes comprehensive quality control testing and is accompanied by a detailed Certificate of Analysis (CoA), providing researchers with confidence in product identity, purity, and performance.

Designed exclusively for qualified research laboratories, SM-GLP1 delivers the quality and consistency required for advanced scientific investigations.

Product Highlights

• Premium reagent-grade Sema research peptide
• Long-acting GLP-1 receptor agonist
• ≥95% HPLC-verified purity
• Lyophilized powder for laboratory research
• 31-amino-acid GLP-1 analog
• Molecular weight: 4113.64 g/mol
• High batch-to-batch consistency
• Third-party analytical verification available
• Certificate of Analysis included with every batch
• Intended exclusively for research applications

Product Description

SM-GLP1 is a chemically synthesized 31-amino-acid GLP-1 analog designed with advanced peptide engineering techniques to enhance molecular stability and support laboratory investigations. The peptide incorporates carefully selected structural modifications that improve resistance to enzymatic degradation while extending stability in experimental models.

Recognized for its selective interaction with the glucagon-like peptide-1 receptor (GLP-1R), SM-GLP1 is frequently used in scientific research exploring receptor pharmacology, intracellular signaling pathways, peptide-receptor interactions, and structure-activity relationships.

Researchers utilize this peptide in studies examining cAMP-mediated signaling, receptor activation, ligand binding characteristics, and peptide engineering strategies within controlled laboratory environments.

Advanced Structural Design

SM-GLP1 incorporates multiple structural modifications that distinguish it from native GLP-1 and improve its suitability for research applications.

At position 8, the native alanine residue is replaced with α-aminoisobutyric acid (Aib), a well-established modification that enhances resistance to DPP-4 enzymatic degradation and improves peptide stability during experimental studies.

At position 26, a C18 fatty acid is attached through a γ-glutamic acid and AEEA spacer linker. This lipid conjugation strategy has been widely investigated for promoting reversible albumin binding in serum-based research models and extending peptide persistence under laboratory conditions.

An arginine substitution at position 34 is incorporated to reduce undesired acylation while supporting consistent peptide synthesis and analytical performance.

These engineered modifications provide researchers with a highly characterized peptide suitable for advanced biochemical, molecular biology, and pharmacological investigations.

Research Applications

SM-GLP1 is intended exclusively for laboratory research conducted by qualified professionals.

Common areas of scientific investigation include:

• GLP-1 receptor pharmacology
• GPCR signaling research
• cAMP and PKA pathway studies
• Peptide stability analysis
• Ligand-receptor interaction research
• Structure-activity relationship (SAR) studies
• Metabolic pathway investigations
• Molecular biology research
• Analytical assay development
• Peptide formulation and characterization

This product is supplied solely for in-vitro laboratory use and should only be handled by trained research personnel in appropriate laboratory settings.

Product Specifications

Storage & Handling

To maintain peptide integrity, SM-GLP1 should be stored in its original lyophilized form at −20°C, protected from moisture, heat, and direct light.

Following reconstitution, researchers should prepare aliquots for storage at ultra-low temperatures while minimizing repeated freeze-thaw cycles to preserve peptide stability and analytical performance.

When stored under recommended conditions, the lyophilized product maintains long-term stability suitable for laboratory research.

Quality Assurance

Every batch of SM-GLP1 undergoes extensive quality control before release.

Each shipment includes a comprehensive Certificate of Analysis (CoA) featuring:

• HPLC purity analysis (≥95%)
• Mass spectrometry molecular weight confirmation
• Identity verification
• Batch-specific analytical documentation
• Independent third-party testing available

These quality standards ensure researchers receive a highly characterized and reproducible research peptide suitable for demanding laboratory applications.

Research Use Only

SM-GLP1 (Sema) is supplied exclusively as a reagent-grade research compound.

This product is intended only for in-vitro laboratory research, analytical testing, and scientific investigation. It is not approved by the U.S. Food and Drug Administration (FDA) for clinical, therapeutic, diagnostic, or veterinary use.